175 related articles for article (PubMed ID: 34992585)
21. [Progress in Research on Structure, Function and Antiviral of Enterovirus A71 3C Protein].
Li J; Wen H; Wang Z
Bing Du Xue Bao; 2015 Jul; 31(4):468-73. PubMed ID: 26524922
[TBL] [Abstract][Full Text] [Related]
22. Translocating lipopolysaccharide correlates with the severity of enterovirus A71-induced HFMD by promoting pro-inflammation and viral IRES activity.
Wang Y; Dan K; Xue X; Yang X; Feng X; Yang Q; Yang J; Chen B
Gut Pathog; 2021 Nov; 13(1):69. PubMed ID: 34809671
[TBL] [Abstract][Full Text] [Related]
23. Human tryptophanyl-tRNA synthetase is an IFN-γ-inducible entry factor for Enterovirus.
Yeung ML; Jia L; Yip CCY; Chan JFW; Teng JLL; Chan KH; Cai JP; Zhang C; Zhang AJ; Wong WM; Kok KH; Lau SKP; Woo PCY; Lo JYC; Jin DY; Shih SR; Yuen KY
J Clin Invest; 2018 Nov; 128(11):5163-5177. PubMed ID: 30153112
[TBL] [Abstract][Full Text] [Related]
24. Pim1 Impacts Enterovirus A71 Replication and Represents a Potential Target in Antiviral Therapy.
Zhou F; Wan Q; Lu J; Chen Y; Lu G; He ML
iScience; 2019 Sep; 19():715-727. PubMed ID: 31476618
[TBL] [Abstract][Full Text] [Related]
25. Enterovirus A71 Containing Codon-Deoptimized VP1 and High-Fidelity Polymerase as Next-Generation Vaccine Candidate.
Tsai YH; Huang SW; Hsieh WS; Cheng CK; Chang CF; Wang YF; Wang JR
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996087
[TBL] [Abstract][Full Text] [Related]
26. Enterovirus A71 Infection Activates Human Immune Responses and Induces Pathological Changes in Humanized Mice.
Ke Y; Liu WN; Her Z; Liu M; Tan SY; Tan YW; Chan XY; Fan Y; Huang EK; Chen H; En Chang KT; Chan JKY; Hann Chu JJ; Chen Q
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429352
[TBL] [Abstract][Full Text] [Related]
27. EV-A71 induced IL-1β production in THP-1 macrophages is dependent on NLRP3, RIG-I, and TLR3.
Huang HI; Chio CC; Lin JY; Chou CJ; Lin CC; Chen SH; Yu LS
Sci Rep; 2022 Dec; 12(1):21425. PubMed ID: 36503883
[TBL] [Abstract][Full Text] [Related]
28. Exosomal MicroRNA-155 Inhibits Enterovirus A71 Infection by Targeting PICALM.
Wu J; Gu J; Shen L; Fang D; Zou X; Cao Y; Wang S; Mao L
Int J Biol Sci; 2019; 15(13):2925-2935. PubMed ID: 31853228
[TBL] [Abstract][Full Text] [Related]
29. Enterovirus A71 and coxsackievirus A16 show different replication kinetics in human neuronal and non-neuronal cell lines.
Yogarajah T; Ong KC; Perera D; Wong KT
Arch Virol; 2017 Mar; 162(3):727-737. PubMed ID: 27878462
[TBL] [Abstract][Full Text] [Related]
30. 3C
Wu X; Chen L; Sui C; Hu Y; Jiang D; Yang F; Miller LC; Li J; Cong X; Hrabchenko N; Lee C; Du Y; Qi J
Virol Sin; 2023 Jun; 38(3):387-397. PubMed ID: 36921803
[TBL] [Abstract][Full Text] [Related]
31. A Novel Attenuated Enterovirus A71 Mutant with VP1-V238A,K244R Exhibits Reduced Efficiency of Cell Entry/Exit and Augmented Binding Affinity to Sulfated Glycans.
Meng T; Wong SM; Chua KB
J Virol; 2021 Oct; 95(22):e0105521. PubMed ID: 34468173
[TBL] [Abstract][Full Text] [Related]
32. Development of a full-length cDNA-derived enterovirus A71 vaccine candidate using reverse genetics technology.
Yang YT; Chow YH; Hsiao KN; Hu KC; Chiang JR; Wu SC; Chong P; Liu CC
Antiviral Res; 2016 Aug; 132():225-32. PubMed ID: 27387826
[TBL] [Abstract][Full Text] [Related]
33. Cellular receptors for enterovirus A71.
Kobayashi K; Koike S
J Biomed Sci; 2020 Jan; 27(1):23. PubMed ID: 31924205
[TBL] [Abstract][Full Text] [Related]
34. Viral determinants that drive Enterovirus-A71 fitness and virulence.
Ang PY; Chong CWH; Alonso S
Emerg Microbes Infect; 2021 Dec; 10(1):713-724. PubMed ID: 33745413
[TBL] [Abstract][Full Text] [Related]
35. Pyroptosis induced by enterovirus A71 infection in cultured human neuroblastoma cells.
Zhu X; Wu T; Chi Y; Ge Y; Wu B; Zhou M; Zhu F; Ji M; Cui L
Virology; 2018 Aug; 521():69-76. PubMed ID: 29886343
[TBL] [Abstract][Full Text] [Related]
36. Metabolic Profiling Reveals Significant Perturbations of Intracellular Glucose Homeostasis in
Zou Z; Tsang JO; Yan B; Chik KK; Chan CC; Cao J; Liang R; Tang K; Yin F; Ye ZW; Chu H; Chan JF; Yuan S; Yuen KY
Metabolites; 2020 Jul; 10(8):. PubMed ID: 32717953
[No Abstract] [Full Text] [Related]
37. Clinical characteristics and managements of severe hand, foot and mouth disease caused by enterovirus A71 and coxsackievirus A16 in Shanghai, China.
Cai K; Wang Y; Guo Z; Yu H; Li H; Zhang L; Xu S; Zhang Q
BMC Infect Dis; 2019 Mar; 19(1):285. PubMed ID: 30917800
[TBL] [Abstract][Full Text] [Related]
38. Exosomes Facilitate Transmission of Enterovirus A71 From Human Intestinal Epithelial Cells.
Huang HI; Lin JY; Chiang HC; Huang PN; Lin QD; Shih SR
J Infect Dis; 2020 Jul; 222(3):456-469. PubMed ID: 32271384
[TBL] [Abstract][Full Text] [Related]
39. Immune responses against enterovirus A71 infection: Implications for vaccine success.
Aw-Yong KL; NikNadia NMN; Tan CW; Sam IC; Chan YF
Rev Med Virol; 2019 Sep; 29(5):e2073. PubMed ID: 31369184
[TBL] [Abstract][Full Text] [Related]
40. Antiviral Peptides Targeting the Helicase Activity of Enterovirus Nonstructural Protein 2C.
Fang Y; Wang C; Wang C; Yang R; Bai P; Zhang XY; Kong J; Yin L; Qiu Y; Zhou X
J Virol; 2021 May; 95(12):. PubMed ID: 33789997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
